Teleflex Incorporated Signs New Agreement with Premier Inc. for Implantable Infusion Ports
October 28 2016 - 5:45AM
Business Wire
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical technologies for critical care and surgery, has announced a
new group purchasing agreement with Premier Inc. – a leading
healthcare improvement company, uniting an alliance of
approximately 3,750 US hospitals and 130,000 other providers to
transform healthcare. The new agreement covers the Polysite® Low
Profile Hybrid Ports. The agreement begins November 1, 2016, and
extends through October 31, 2019.
The Polysite® Low Profile Hybrid Ports are designed to
enhance patient comfort while simultaneously providing clinicians
with unique product enhancements. The low-profile design
incorporates hybrid technology with a durable titanium reservoir
and a lightweight atraumatic-angled shell. The ports have a large
septum for easy access and include a radiopaque locking collar for
safe attachment to catheters. They are available in both
pressure-injectable and non-pressure-injectable options in 6Fr, 7Fr
and 8Fr sizes.
“Arrow® Interventional Access products from Teleflex provide
economical solutions and help clinicians to reduce complications,”
said Jay White, President and General Manager, Vascular Division of
Teleflex. “We’re pleased to offer Premier members the clinical and
financial benefits of the Polysite Ports under this new
agreement.”
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose-driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rusch® and Weck® – trusted brands united by a common
sense of purpose.
Polysite is a registered trademark of Perouse Medical SAS.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA,
Pilling, Rusch and Weck are trademarks or registered trademarks of
Teleflex Incorporated or its affiliates, in the U.S. and/or other
countries.© 2016 Teleflex Incorporated. All rights reserved.
MC-002818
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161028005019/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2024 to May 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From May 2023 to May 2024